Literature DB >> 15947822

[Swallowing after chemotherapy and radiotherapy for laryngeal and hypopharyngeal carcinomas].

Andréa Bizarria Cintra1, Luciana Passuello do Vale, Olavo Feher, Inês Nobuko Nishimoto, Luiz Paulo Kowalski, Elisabete Carrara de Angelis.   

Abstract

UNLABELLED: The main goals of the larynx preservation protocol are eradication of cancer and preservation of a functional larynx with maintenance of respiration, phonation and swallowing. Few studies, however have addressed functional outcomes.
OBJECTIVE: Functional evaluation of oropharyngeal swallowing in patients enrolled in a larynx preservation protocol at the Hospital do Câncer AC Camargo.
METHODS: Evaluation of swallowing was performed by videofluoroscopy in 31 patients, focusing on: oropharyngeal motility disorders, stasis, laryngeal penetration, aspiration and severity of dysphagia.
RESULTS: Swallowing analysis: 5 patients showed inefficient bolus preparation, 14 had changes in the bolus propulsion; 23 patients had a reduced laryngeal elevation, 26 presented with stasis in the vallecula and 14 with stasis in hypopharynx. Nine patients presented silent aspiration. We detected functional swallowing in 11 patients; mild dysphagia in 7; mild/moderate in 7; moderate in 3 and severe dysphagia in 3.
CONCLUSION: Larynx preservation results in changes of swallowing, ranging in their majority from discrete to moderate. Some patients, however, developed severe dysphagia, and oral feeding was not possible.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947822     DOI: 10.1590/s0104-42302005000200016

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  1 in total

1.  [Swallowing after non-surgical treatment (radiation therapy / radiochemotherapy protocol) of laryngeal cancer].

Authors:  Juliana Portas; Claudia Pereira Socci; Eliana Perissato Scian; Débora Dos Santos Queija; Alessandra Sampaio Ferreira; Rogério Aparecido Dedivitis; Ana Paula Brandão Barros
Journal:  Braz J Otorhinolaryngol       Date:  2011 Jan-Feb
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.